Advancing Cardiovascular Safety Assessment with Implanted Telemetry Study in Beagle Dogs
Discover how Palamur Biosciences advances cardiovascular safety assessment through implanted telemetry studies. With 25+ GLP studies submitted to global regulators, our FDA-audited, AAALAC-accredited CRO delivers high-resolution, long-term data for IND-enabling and early-stage drug development programmes.
Critical Role of NHP Models in Evaluating Advanced Therapeutic Modalities
Discover how Palamur Biosciences is advancing drug development with state-of-the-art preclinical research using Rhesus monkey models. From CAR-T therapy to gene therapy and vaccine efficacy studies, explore our GLP-certified, AAALAC-accredited platform for highly translatable safety and efficacy data.
Breaking Barriers to Oral Bioavailability: Multi-site Splanchnic Vein Sampling in an Imaging-Enabled Canine PK Study by Palamur Biosciences
Discover how Palamur Biosciences used imaging-guided splanchnic vein sampling in dogs to decode oral bioavailability and inform formulation strategies.
US FDA BIMO investigations @palamur biosciences (Palamur ) and acceptance of the PBS data by US EPA
Any pre-clinical study conducted as per OECD GLP Principles and supporting documents complying to Indian GLP regulations MHFW ( Ministry of Health and Family Welfare), Drugs and Cosmetic Rules, 1945, as amended 31 Dec 2016, Schedule L-1 and claiming compliance to USFDA GLP 21 CFR Part 58 regulations needs to demonstrate properly on demand in terms of reconstruction and traceability of study documents as detailed below (item 2) during the GLP regulatory investigations .
Plan for 2025-26 - Reflecting on US FDA and BIMO Audit Investigations at Palamur Biosciences (Palamur ) / Acceptance of PBS Data by US EPA and our Learnings
Plan for 2025-26 - Reflecting on US FDA and BIMO Audit Investigations at Palamur Biosciences (Palamur ) / Acceptance of PBS Data by US EPA and our learnings
Reflecting on the past and building the future based on the learning at Palamur Biosciences (PBS) – US EPA Data Acceptance & Positive expectation on US FDA BIMO Investigation
Palamur Biosciences reflects on key learnings from US FDA BIMO and US EPA audits, highlighting regulatory compliance, data integrity, and preclinical research advancements. Read the Chairman’s insights on resilience, growth, and future opportunities in 2025
Palamur Biosciences Achieves Prestigious OLAW Certification
Palamur Biosciences earns OLAW certification in 2025, advancing preclinical research with diverse animal models in Telangana, India
Palatability Trials for Feed, Treat and Veterinary Medical Products (VMPs)
Palatability can be defined as the measure of intake of feed or treat based on quality or preferences.
In-Vivo Dermal Pharmacokinetic Study using Swine Models
In-Vivo Dermal Pharmacokinetic Study (Swine Models)
MACROSCOPIC AND MICROSCOPIC EVALUATION OF WOUND HEALING in SWINE MODELS
Preclinical wound models that are capable of properly recapitulating human wounds with different circumstances like...
